Name | 6,8-dihydropyrrolo[2,3-g][1,3]benzothiazol-7-one |
---|---|
Synonyms |
7H-Thiazolo[5,4-e]indol-7-one
6.8-dihydro-1-thia-3,6-diaza-as-indacen-7-one 7H-[1,3]Thiazolo[5,4-e]indol-7-one 7H-Pyrrolo[2,3-g]benzothiazol-7-one,6,8-dihydro-(9CI) |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 441.2±55.0 °C at 760 mmHg |
Molecular Formula | C9H4N2OS |
Molecular Weight | 188.206 |
Flash Point | 220.6±31.5 °C |
Exact Mass | 188.004440 |
PSA | 73.72000 |
LogP | 0.80 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.865 |
HS Code | 2934999090 |
---|
~68% 222036-27-3 |
Literature: Glaxo Wellcome Inc. Patent: US6350747 B1, 2002 ; Location in patent: Page column 47 ; |
~% 222036-27-3 |
Literature: SmithKline Beecham Corporation Patent: US6369086 B1, 2002 ; US 6369086 B1 |
~% 222036-27-3 |
Literature: Bramson; Holmes; Hunter; Lackey; Lovejoy; Luzzio; Montana; Rocque; Rusnak; Shewchuk; Veal; Corona; Walker; Kuyper; Davis; Dickerson; Edelstein; Frye; Gampe Jr.; Harris; Hassell Journal of Medicinal Chemistry, 2001 , vol. 44, # 25 p. 4339 - 4358 |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |